RuthELamarMD

PubMed

• 27 citations
  Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
  Denise A. Yardley, Patrick J. Ward, Brooke R. Daniel, Janice F. Eakle, Ruth E. Lamar, Cassie M. Lane, John D. Hainsworth> ;Clinical Breast Cancer. 2016 Oct 1
• 104 citations
  Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
  John D. Hainsworth, Thomas J. Ervin, Elke K. Friedman, Victor M. Priego, Patrick B. Murphy, Bobby L. Clark, Ruth E. Lamar> ;Cancer. 2010 Aug 1
• Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM).
  Lamar RE, Spigel DR, Burris HA, Markus TM, Kuzur M, Ervin T, Fichtel L, Greco FA, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
• A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors.
  Doss HH, Jones SF, Infante JR, Spigel DR, Willcutt N, Lamar R, Barton J, Keegan M, Burris HA> ;J. Clin. Oncol.. 2008-05-20
• 40 citations
  Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
  Vinicius Ludwig, Sarina Fordice, Ruth Lamar, William H. Martin, Dominique Delbeke> ;Clinical Nuclear Medicine. 2003 Mar 1
• 56 citations
  T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.
  John P. Greer, William R. Macon, Ruth E. Lamar, Steven N. Wolff, Richard S. Stein, John M. Flexner, Robert D. Collins, John B. Cousar> ;Journal of Clinical Oncology. 1995 Jul 1
• 7 citations
  High‐dose, brief duration, multiagent chemotherapy for metastatic breast cancer
  Ruth E. Lamar, F. Anthony Greco, David H. Johnson, Patrick B. Murphy, John D. Hainsworth> ;Cancer. 1994 Apr 1
• Join now to see all